$2.92 Million is the total value of Camber Capital Management LP's 39 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNY | Sell | SANOFIsponsored adr | $339,010 | -99.9% | 7,000,000 | -6.7% | 11.63% | +33.2% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $239,513 | -99.9% | 1,700,000 | -24.4% | 8.22% | +35.2% |
| VTRS | Sell | VIATRIS INC | $222,600 | -99.9% | 20,000,000 | -33.3% | 7.64% | -2.5% |
| THC | Buy | TENET HEALTHCARE CORP | $195,160 | -99.9% | 4,000,000 | +33.3% | 6.69% | +41.3% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $186,800 | -99.8% | 5,000,000 | +77.0% | 6.41% | +135.9% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $161,975 | -99.9% | 1,250,000 | -16.7% | 5.56% | +9.4% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $159,375 | -99.9% | 1,250,000 | -10.7% | 5.47% | +22.0% |
| Buy | GSK PLCsponsored adr | $131,775 | -99.8% | 3,750,000 | +50.0% | 4.52% | +100.6% | |
| SEM | SELECT MED HLDGS CORP | $119,184 | -99.9% | 4,800,000 | 0.0% | 4.09% | +25.9% | |
| PTCT | Buy | PTC THERAPEUTICS INC | $104,968 | -99.9% | 2,750,000 | +12.2% | 3.60% | -4.4% |
| MYGN | Buy | MYRIAD GENETICS INC | $101,570 | -99.9% | 7,000,000 | +40.0% | 3.48% | +19.3% |
| PRGO | PERRIGO CO PLC | $85,225 | -99.9% | 2,500,000 | 0.0% | 2.92% | +7.1% | |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $79,088 | -99.8% | 375,000 | +87.5% | 2.71% | +114.0% |
| IONS | IONIS PHARMACEUTICALS INC | $72,707 | -99.9% | 1,925,000 | 0.0% | 2.49% | -4.3% | |
| SGEN | Buy | SEAGEN INC | $64,255 | -99.8% | 500,000 | +100.0% | 2.20% | +110.5% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $63,840 | -99.9% | 7,000,000 | -6.7% | 2.19% | +18.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $63,434 | -100.0% | 1,400,000 | -30.0% | 2.18% | -49.1% |
| XRAY | Buy | DENTSPLY SIRONA INC | $56,198 | -99.9% | 1,765,000 | +24.7% | 1.93% | +56.9% |
| VTRS | New | VIATRIS INCcall | $55,650 | – | 5,000,000 | +100.0% | 1.91% | – |
| BKD | Buy | BROOKDALE SR LIVING INC | $49,140 | -99.9% | 18,000,000 | +12.5% | 1.68% | -19.5% |
| QTRX | Buy | QUANTERIX CORP | $47,436 | -99.9% | 3,425,000 | +14.2% | 1.63% | +60.8% |
| QGEN | New | QIAGEN NV | $37,403 | – | 750,000 | +100.0% | 1.28% | – |
| REPL | New | REPLIMUNE GROUP INC | $27,200 | – | 1,000,000 | +100.0% | 0.93% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $26,698 | – | 700,000 | +100.0% | 0.92% | – |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $24,360 | -99.9% | 1,050,000 | 0.0% | 0.84% | +62.1% | |
| ZIMVIE INC | $24,284 | -99.9% | 2,600,000 | 0.0% | 0.83% | +6.0% | ||
| EXEL | EXELIXIS INC | $21,654 | -99.9% | 1,350,000 | 0.0% | 0.74% | +14.7% | |
| NUVA | NUVASIVE INC | $20,620 | -99.9% | 500,000 | 0.0% | 0.71% | +5.4% | |
| OSUR | ORASURE TECHNOLOGIES INC | $20,485 | -99.9% | 4,250,000 | 0.0% | 0.70% | +42.6% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $17,914 | -99.8% | 4,235,000 | 0.0% | 0.61% | +100.0% | |
| CSII | CARDIOVASCULAR SYS INC DEL | $17,706 | -99.9% | 1,300,000 | 0.0% | 0.61% | +10.0% | |
| PTON | Sell | PELOTON INTERACTIVE INC | $15,880 | -99.9% | 2,000,000 | -33.3% | 0.54% | -14.4% |
| GKOS | GLAUKOS CORP | $15,288 | -99.9% | 350,000 | 0.0% | 0.52% | -8.2% | |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $11,955 | -99.9% | 1,500,000 | +50.0% | 0.41% | +4.9% |
| New | BROOKDALE SR LIVING INCunit 11/15/2023 | $11,058 | – | 250,000 | +100.0% | 0.38% | – | |
| New | SOLID BIOSCIENCES INC | $7,631 | – | 1,418,439 | +100.0% | 0.26% | – | |
| INGN | Sell | INOGEN INC | $6,012 | -100.0% | 305,000 | -63.0% | 0.21% | -66.4% |
| CANO | Sell | CANO HEALTH INC | $5,480 | -100.0% | 4,000,000 | -20.0% | 0.19% | -85.8% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $5,117 | – | 110,000 | +100.0% | 0.18% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -506,000 | -100.0% | -0.38% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -500,000 | -100.0% | -0.38% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -2,865,000 | -100.0% | -0.54% | – |
| SNY | Exit | SANOFIcall | $0 | – | -1,000,000 | -100.0% | -1.16% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -500,000 | -100.0% | -1.24% | – |
| Exit | QUIDELORTHO CORP | $0 | – | -600,000 | -100.0% | -1.31% | – | |
| INCY | Exit | INCYTE CORP | $0 | – | -750,000 | -100.0% | -1.53% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -200,000 | -100.0% | -1.64% | – |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -2,325,000 | -100.0% | -1.96% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -800,000 | -100.0% | -2.08% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -500,000 | -100.0% | -3.01% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -2,500,000 | -100.0% | -3.35% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -1,500,000 | -100.0% | -3.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.